In patients with end-stage renal disease (ESRD) undergoing renal replacement therapy, OPG concentrations are elevated, both in the group treated with peritoneal dialysis and in those performing hemodialysis [15]. This evidence concerns the gene TNFRSF11B and chronic kidney disease.